Cyanide poisoning following prolonged infusion of Sodium Nitroprusside: A case report
Article Sidebar
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Downloads
Societal impact
Main Article Content
Abstract
Sodium Nitroprusside has been approved since 1974 as a medication for hypertensive crises. However, there has been ongoing controversy regarding its potential toxicity. Cyanide toxicity is a rare complication of Sodium Nitroprusside, which can be challenging to diagnose in critically ill patients. Risk factors include prolonged infusions and high doses; hence it is suggested that the dose should not exceed 2 μg/kg/min. Here, we present the case of a 49-year-old patient who entered the emergency department after a cerebrovascular event and a hypertensive emergency that required Sodium Nitroprusside infusion, followed by signs and symptoms suggestive of toxicity. Neurological changes were predominant among these symptoms, and the patient was managed with sodium thiosulfate, resulting in a good response. The objective of this case report is to raise awareness among healthcare professionals about the need for appropriate use of Sodium Nitroprusside and the importance of suspecting toxicity in patients with risk factors.
Article Details
References
Udeh CI, Ting M, Arango M, Mick S. Delayed presentation of nitroprusside-induced cyanide toxicity. Ann Thorac Surg. 2015;99(4):1432-4.
Lockwood Al, Patka J, Rabinovich M. Sodium nitroprusside-associated cyanide toxicity in adult patients – fact or fiction? A critical review of the evidence and clinical relevance. Op Acc Jour Clin Trials. 2010:2;133–148.
Rindone JP, Sloane EP. Cyanide toxicity from sodium nitroprusside: Risks and management. Ann Pharmacother. 1992;26(4):515-9.
Moffett BS, Price JF. Evaluation of sodium nitroprusside toxicity in pediatric cardiac surgical patients. Ann Pharmacother. 2008;42(11):1600-4.
Meyer S, Baghai A, Sailer NL, Gottschling S. Lactic acidosis caused by sodium nitroprusside in a newborn with congential heart disease. Eur J Pediatr. 2005;164(4):253-4.
Morocco AP. Cyanides. Crit Care Clin. 2005;21(4):691-705.
G Nicoletta, M Cascelli, L Marchesini, S Tesoro. A probable case of nitroprusside intoxication. Minerva Anestesiol. 2007;73(9):471-3.
Morris AA, Page RL, Baumgartner LJ, Mueller SW, MacLaren R, Fish DN, et al. Thiocyanate accumulation in critically ill patients receiving nitroprusside infusions. J Intensive Care Med. 2017;32(9):547-553.
Ballesteron M, Carrión F, Casannueva L. Intoxicación por nitroprusiato. An Pediatr 2003;58(1):77-88.
Ivankovich AD, Miletich DJ, Tinker JH. Sodium nitroprusside: Metabolism and general considerations. Int Anesthesiol Clin. 1978;16:1- 29.
Smith RP, Kruzyna H. Nitroprusside produces cyanid poisoning via reaction with hemoglobin. J Pharmacol Exp Ther. 1974;191:557–63.
Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, pathophisiology and pharmacology. Pharmacol Rev. 1991;43:109–42.
Cheung AT, Cruz-Shiavone GE, Meng QC, Pochettino A, Augoustides JA, Bavaria JE, et al. Cardiopulmonary bypass, hemolysis, and nitroprusside-induced cyanide production. Anesth Analg. 2007;105(1):29-33.
McEvoy GK. American hospital formulary service, drug information. 1994;24(08):1163-6.
Friederich JA, Butterworh JF. Sodium nitroprusside: Twenty years and counting Anesth Analg. 1995;81(1):152-62.
Estrada AF, Zuluaga M, Berrouet MC. Intoxicación por cianuro, perspectiva desde urgencias: reporte de dos casos y revisión de la literatura. Med UPB. 2019;38(2):168-176.
Mégarbane B, Delahaye A, Goldgran-Tolédano D, Baud FJ. Antidotal treatment of cyanide poisoning. J Chin Med Assoc. 2003;66(4):193-203.
Shepherd G, Vélez LI. Role of hydroxocobalamin in acute cyanide poisoning. Ann Pharmacother. 2008;42(5):661-9.
Hall AH, Doutre WH, Ludden T, Kulig KW, Rumack BH. Nitrite/thiosulfate treated acute cyanide poisoning: Estimated kinetics after antidote. J Toxicol Clin Toxicol. 1987;25(1-2):121-133.
Schulz V. Clinical pharmacokinetics of nitroprusside, cyanide, thiosulphate and thiocyanate. Clin Pharmacokinet. 1984;9(3):239-51.
Nessim SJ, Richardson RM. Dialysis for thiocyanate intoxication: A case report and review of the literature. ASAIO J. 2006:52(4):479-481.
Cheung AT, Cruz-Shiavone GE, Meng QC. Cardiopulmonary bypass, hemolysis, and nitroprussideinduced cyanide production. Anesth Analg. 2007;105(1):29-33.
Jeffrey A, Friederich MD. Sodium nytroprusside: Twenty years and counting. Anesth Analg. 1995;81:152-62.
Baud FJ, Borrow SW, Bavoux E. Relation between plasma lactate and blood cyanide concentrations in acute cyanide poisoning. BMJ. 1996;312:26-7.
Rindone JP, Sloane EP. Cyanide toxicity from sodium nitroprusside: Risks and management. Ann Pharmacother. 1992;26(4):515-9.
Krapez JR, Vesey CJ, Adams L, Cole PV. Effects of cyanide antidotes used with sodium nitroprusside infusions: Sodium thiosulphate and hydroxocobalamin given prophylactically to dogs. Br J Anaesth. 1981;53(8):793-804.
Nessim SJ, Richardson RM. Dialysis for thiocyanate intoxication: A case report and review of the literature. ASAIO J. 2006;52(4):479-81.
Nicoletta G, Cascelli M, Marchesini L, Tesoro S. A probable case of nitroprusside intoxication. Minerva Anestesiol. 2007;73(9):471-3.
Marbury TC, Sheppard JE, Gibbons K, Lee CS. Combined antidotal and hemodialysis treatments for nitroprusside-induced cyanide toxicity. J Toxicol Clin Toxicol. 1982;19(5):475-82.
Hall AH, Rumack BH. Hydroxycobalamin/sodium thiosulfate as a cyanide antidote. J Emerg Med. 1987;5(2):115-21.
Nessim SJ, Richardson RM. Dialysis for thiocyanate intoxication: a case report and review of the literature. ASAIO J. 2006;52(4):479-81.